Beam Therapeutics Inc. ( BEAM) - Key Metrics
BEAM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.18 | -$0.63 | -$0.66 |
| 2026Q1 | $0.31 | -$0.91 | -$1.24 | -$1.27 |
| 2025Q4 | $1.11 | $2.37 | -$0.81 | -$0.85 |
| 2025Q3 | $0.09 | -$1.10 | -$0.79 | -$0.84 |
| 2025Q2 | $0.08 | -$1 | -$0.75 | -$0.78 |
BEAM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.27 |
| 2026Q1 | 0% | -6.55 |
| 2025Q4 | 0% | 2.92 |
| 2025Q3 | 0% | -5.52 |
| 2025Q2 | 0% | -4.25 |
BEAM
Price: $24.73
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.69 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Market Capitalization: 2.6 billion